ORCL three-lens brief
Evidence-based stock research on ORCL. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Price up 5.74% in the last session — a material single-day move. · Negative free cash flow last quarterly (-$22.30B).
- Price up 5.74% in the last session — a material single-day move.
- Outperforming SPY by 10.1pp over 30 days.
- Analyst mean target $243.23 — 34% above current (39 analysts).
- Negative free cash flow last quarterly (-$22.30B).
- Debt-to-equity of 415.3 — balance-sheet-heavy.
ORCL closed at $181.69 (+5.74%) as of 2026-05-04. Market cap: $522.53B. P/E (trailing) 32.6. Positives: price up 5.74% in the last session — a material single-day move.; outperforming SPY by 10.1pp over 30 days.. Concerns: negative free cash flow last quarterly (-$22.30B).; debt-to-equity of 415.3 — balance-sheet-heavy.. Last quarter: Revenue $17.19B, net income $3.70B, free cash flow -$22.30B.
Why three lenses on ORCL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ORCLacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ORCL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ORCL brief"></iframe>